# PepGen Inc. (PEPG) fundamentals

Data as of 2026-11-11. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $4.61, market value $319 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). PepGen Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / book: 2.7×**. The shares trade at 2.7× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -21.8%** (5-yr avg -43.4%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Return on equity: -60.8%**. Return on equity is negative because earnings are negative.

## Growth
- **EPS growth (1 yr): 25.6%**. Earnings per share rose 25.6%.

## Financial health
- **Current ratio: 11.94** (quick 11.94). Current assets cover the next year's liabilities 11.94 times.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. PepGen Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -48.3%** (YTD -63.3%, 3-mo -20.1%). The shares are down 48.3% over twelve months including dividends.
- **From 52-week high: -40.9%** (251.9% above the low). Trading 41% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 45**. An RSI of 45 is neutral.
- **Beta (1 yr): 0.34** (volatility 107%). Beta of 0.34 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=PEPG · Page: https://foliofundamentals.com/stocks/pepg

Not investment advice.